Ovarian Endometrioid Adenocarcinoma

Showing 26 - 38 of 38

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma Trial in United

Completed
  • Ovarian Clear Cell Cystadenocarcinoma
  • +7 more
  • Bevacizumab
  • +4 more
  • Aurora, Colorado
  • +12 more
Jul 19, 2019

Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma Trial in Seattle (biological,

Completed
  • Fallopian Tube Cancer
  • +10 more
  • denileukin diftitox
  • +4 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
May 13, 2019

Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma Trial in United

Completed
  • Ovarian Clear Cell Cystadenocarcinoma
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +6 more
Mar 8, 2019

Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, Endometrial Serous Adenocarcinoma Trial in Canada,

Completed
  • Adult Hepatocellular Carcinoma
  • +44 more
  • Scottsdale, Arizona
  • +60 more
Jan 24, 2019

Nausea and Vomiting, Ovarian Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma Trial in Hinsdale, Providence (procedure,

Terminated
  • Nausea and Vomiting
  • +26 more
  • Adjuvant Therapy
  • +7 more
  • Hinsdale, Illinois
  • +1 more
Apr 24, 2018

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Unknown status
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +32 more
  • Behavioral Dietary Intervention
  • +7 more
  • Birmingham, Alabama
  • +686 more
Feb 14, 2018

Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma Trial in Seattle (biological, drug, other)

Completed
  • Brenner Tumor
  • +11 more
  • sargramostim
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Jul 24, 2017

Malignant Ovarian Mixed Epithelial Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma Trial in

Terminated
  • Malignant Ovarian Mixed Epithelial Tumor
  • +7 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Aug 8, 2017

Fallopian Tube Carcinoma, Malignant Ovarian Mixed Epithelial Tumor, Ovarian Brenner Tumor Trial in Philadelphia (Carboplatin,

Completed
  • Fallopian Tube Carcinoma
  • +10 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
May 7, 2015

Fatigue, Malignant Ovarian Mixed Epithelial Tumor, Neuropathy Trial (Acetyl-L-Carnitine Hydrochloride, Placebo, Questionnaire

Withdrawn
  • Fatigue
  • +12 more
  • Acetyl-L-Carnitine Hydrochloride
  • +3 more
  • (no location specified)
Dec 29, 2014

Adenocarcinoma of the Colon, Adenocarcinoma of the Gallbladder, Adenocarcinoma of the Pancreas Trial in Philadelphia

Completed
  • Adenocarcinoma of the Colon
  • +41 more
  • recombinant fowlpox-CEA(6D)/TRICOM vaccine
  • +2 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jan 24, 2013

Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma Trial in Phoenix (paclitaxel,

Completed
  • Brenner Tumor
  • +8 more
  • Phoenix, Arizona
    Gynecologic Oncology Group of Arizona
Jan 23, 2013